Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Continuous Flow

Expand the established chemistry space with Continuous Flow to deliver robust and sustainable processes.

Page
Read more

Health, Safety, Environment and Energy (HSEEn)

Zero accidents is our main goal

Page
Read more

Process Safety

Process safety is a blend of engineering and management skills that focuses on the prevention of events impacting safety, environmental damage and business losses.

Page
Read more